key: cord-0773868-fcfiiw3j
authors: Blomquist, Paula Bianca; Bolt, Hikaru; Packer, Simon; Schaefer, Ulf; Platt, Steven; Dabrera, Gavin; Gobin, Maya; Oliver, Isabel
title: Risk of symptomatic COVID‐19 due to aircraft transmission: a retrospective cohort study of contact‐traced flights during England’s containment phase
date: 2021-03-01
journal: Influenza Other Respir Viruses
DOI: 10.1111/irv.12846
sha: 080e37d643310087daa6c46a8947e92318029d55
doc_id: 773868
cord_uid: fcfiiw3j

BACKGROUND: Knowledge gaps remain regarding SARS‐CoV‐2 transmission on flights. We conducted a retrospective cohort study to estimate risk of acquiring symptomatic SARS‐CoV‐2 on aircraft, to inform contact tracing and infection control efforts. METHODS: We identified co‐passengers of infectious passengers on 18 England‐bound flights from European cities up to 12/03/2020, using manifests received for contact tracing. Infectious passengers were laboratory‐confirmed cases with symptom onset from 7 days before to 2 days after the flight. Possible aircraft‐acquired cases were laboratory‐confirmed with onset 3‐14 days post‐flight with no known non‐flight exposure. Manifests was merged with the national case management dataset (identifying cases, onset dates, contact tracing status) and the national COVID‐19 linelist. Contact tracing notes were reviewed to identify non‐flight exposures. We calculated attack rates (ARs) among all co‐passengers and within subgroups, including by distance from infectious cases and number of infectious cases on‐board. RESULTS: There were 55 infectious passengers and 2313 co‐passengers, including 2221 flight‐only contacts. Five possible aircraft‐acquired cases were identified; ARs of 0.2% (95%CI 0.1‐0.5) among all flight‐only contacts and 3.8% (95%CI 1.3‐10.6) among contact‐traced flight‐only contacts sat within a two‐seat radius. The AR among 92 co‐travellers with known non‐flight exposure to infectious cases was 13.0% (95%CI 7.6%‐21.4%). There were insufficient numbers to assess differences between subgroups. CONCLUSION: We conclude that risk of symptomatic COVID‐19 due to transmission on short to medium‐haul flights is low, and recommend prioritising contact‐tracing of close contacts and co‐travellers where resources are limited. Further research on risk on aircraft is encouraged.

The COVID-19 pandemic is a global health emergency, 1 with more than 100 million cases reported worldwide by the end of January 2021. 2 During the containment phase in England (up to 12th March 2020), 3 Public Health England (PHE) implemented control measures to prevent case importation. In addition to supported isolation of travellers from high-incidence areas, PHE followed an air travel contact-tracing protocol similar to that of other respiratory infections, which involved identifying cases with recent flight history and liaising with port health authorities and airline companies to identify their contacts. 4 Where reachable, contacts were put under passive surveillance for 14 days from the day of the flight, and, if they developed symptoms, asked to inform PHE and call NHS 111 to get tested.

In doing this, PHE defined an air travel contact as a person sitting within a two seat radius of a confirmed case, or a member of cabin crew serving the area around where the case was seated. 4 The magnitude and determinants of risk of SARS-CoV-2 transmission on aircraft continue to be of public and policy interest. The international aviation industry assesses risk to be low, 5 pointing to high-efficiency particulate air (HEPA) filters installed on aircraft, vertical air flow, and seats acting as physical barriers. Published studies have varied in their risk assessment. There were no secondary cases identified among 350 co-passengers of an infectious case on a 15 hours flight between Wuhan China and Toronto Canada, 6 or among 326 co-passengers monitored in the Northern Territory of Australia. 7 However a case who flew from Central African Republic to France in February 2020 was identified as possibly aircraftacquired, 8 whole-genome sequencing has suggested direct transmission between two passengers and two crew members on a 15 hour flight from Boston to Hong Kong, 9 and there were 16 possible secondary cases identified after exposure on a 10 hours commercial flight from London to Vietnam -an attack rate of 62% in the business class section. 10 A review of SARS case reports of in-flight transmission during the 2003 pandemic found two flights where half of secondary SARS cases were sat beyond the two-row limit, which equated to a total 26% attack rate among passengers sat within two rows of the infectious individual and 7% among passengers sat beyond this. 11 A Lancet meta-analysis determined that infection risk due to physical contact with a contagious person was 13%, and this notably decreased with additional each metre of distance. 12 This study aimed to estimate the risk and modifiable risk factors of symptomatic COVID-19 due to transmission on aircraft, to inform contact-tracing methods, infection prevention and control efforts, as well as travel-related policy and guidance more widely.

This was a retrospective cohort study based on contact-traced international aircrafts that flew to England during the containment period, which occurred between early January and March 12th 2020. Only flights with an available manifest and a known seat number of any presumed infectious cases were included.

Index cases were passengers with a laboratory-confirmed SARS-CoV-2 test with symptom onset between seven days before or up to two days after an international flight.

Cases among flight contacts with symptom onset (or specimen date if symptom dates were missing) between 3 and 14 days after the flight were considered "additional cases." These were subcategorised as follows:

• Possible aircraft-acquired case: confirmed case among copassengers whose only known exposure to the case was on the flight and had no whole-genome sequencing evidence to rule out direct transmission.

• Multiple-exposure case: confirmed case among co-passengers with evidence of household or other travel contact with an index case, as indicated in contact-tracing records or by having the same traveller information in the flight manifest as an index case (same personal contact email, record locator code, or booking reference number in the manifest).

All cases were presumed to be symptomatic, even where onset dates were missing, due to testing criteria at the time. Multipleexposure cases were considered more likely to acquire infection from an index case during close contact outside the flight. We assume that passengers were not wearing masks during the flight due to this being in the early stages of the pandemic before mask wearing was widespread.

We accessed and compiled data from the following sources:

Flight datasets shared by airlines with PHE, which contained passenger names, demographics, home address, booking email addresses, booking reference numbers, and seat numbers.

The case management system used by all local PHE Health Protection Teams to record cases, contacts, and communications related to the case management or contact tracing. The data extracted included details of COVID-19 test results, onset dates, and contextual information such as contacts outside of flights or movement between seats.

A national line list of laboratory-confirmed cases in England reported to PHE, including specimen dates, names, and demographic details of confirmed cases.

Documentation created locally to facilitate the contact-tracing process, including logs of case seat numbers and emails exchanged between PHE staff to initiate and report progress on contact tracing.

An online database of past international flights, including actual recorded length of flight and aircraft model.

Database of SARS-CoV-2 sequences sequenced in England (data release COG20200601), maintained by the COVID-19 Genomics UK consortium.

All available manifests were standardised and appended, then restricted to passengers who had boarded the flight. The full manifest dataset was linked to HPZone data on name as well as date of birth and/or residential postcode to identify cases, onset dates, and persons who were contact traced. Contact-tracing logs and communications were manually reviewed to fill in information gaps and identify persons with multiple-exposures, and FlightAware.com was queried for flight length per flight.

To capture further cases, the manifest dataset was then linked with the England COVID-19 laboratory line list. Line list cases were considered matches if they matched the manifest record exactly on last name and date of birth/postcode, or, if the manifest did not include date of birth/postcode but they matched exactly on name alone and there was evidence of foreign travel to the country in question in HPZone records.

Microsoft Excel was used for data management where manual compilation of information was required. R version 3.5.3 was used for manipulation of datasets, including labelling of cases and exposure categories.

COG-UK data were searched to identify pre-aligned sequences from pairs or groups of index and possible aircraft-acquired cases who shared a flight. Sequences from multiple-exposure cases from these flights or from other flights for which only sequences from index or only possible aircraft-acquired cases were available were selected as background sequences. Pangolin software was used to calculate global lineages, and a phylogenetic tree generated with iqtree2. Pairwise distances between sequences were further calculated using SNP-distances.

The number of additional cases with onset 3 to 14 days after the flight was presented overall and by onset date. Attack rates were calculated among all co-passengers and among those who were successfully contacted to inform them of the contact-tracing and surveillance procedures (referred to as "contact traced" hereafter).

Possible aircraft-acquired cases were identified, taking into account WGS evidence where available, and risk of aircraft transmission was estimated among co-passengers whose only known exposure to the index case was on the flight. This was compared to attack rates among multiple-exposure contacts of index cases. Possible aircraft-acquired cases were described in terms of time, person, and place on the aircraft. Finally, a risk factor analysis was undertaken by presenting attack rates by distance from the index case, number of index cases on the flight or in close proximity, flight length, and city of departure. 

Contact tracing was initiated for 45 flights that landed in England between 31 January and 12 March 2020. Full manifests with unique seat numbers, including at least one seat specified for an index case, were available for 18 flights. These flights departed from across Europe (Table 1) 

Among all 2,313 co-passengers, there were 17 COVID-19 cases with symptom onset or specimen date 3 to 14 days after the flight ( Figure 1 ; Table 2 ). Five of these cases were possible aircraft ac- Among close contacts who were followed up, one in two developed symptomatic COVID-19.

A total of 107 sequences on nine flights were identified. No flights were identified on which sequences were available from both the index case and any of five of the possible aircraft-acquired cases, so this information could not be used to support or rule out direct transmission.

The five possible aircraft-acquired cases were four males and one female ranging between 32 and 60 years of age, who travelled on four flights from Innsbruck, Geneva, and Milan. Their flight times ranged from 109 to 120 minutes. These persons were sat throughout the plane body, and at varying distances from the closest index case(s) ( Figure 2 ): four were sat within two seats, and one was sat five rows away. Each of these flights had at least three index cases and at least one symptomatic index case.

Only one case was detected beyond the two-seat radius eligible for contact tracing and no meaningful difference in crude risk was found comparing to those sat within two seats ( Similarly, attack rates were higher in flights with more index cases, with no additional cases in the four flights with only one index case, three in the ten flights with two to four index cases (0.2% attack rate), and two in the four flights with four or more index cases (0.4%). There were insufficient numbers or variation in flight length to observe patterns by flight length.

In this study of flight, contact-tracing, and laboratory data of passengers on 18 England-bound aircraft, we identified 55 COVID-19

index cases presumed to be infectious during travel. There were 17 further symptomatic COVID-19 cases with symptom onset or specimen dates within 3 to 14 days after the flight. Only five of these individuals were possible aircraft-acquired cases, representing an attack rate of 0.2% among those whose only known encounter with the index case was on the flight, and 3.8% when further restricting to those who were contact-traced. Due to smaller numbers of those contact-traced, the latter estimate ranged from 1.3% to 10.5%

(based on the attack rate confidence interval). These risks were considerably lower than that of multiple-exposure contacts of the index case: 13.0% overall (95% CI 7. tracing. There were no cases among those sat directly adjacent to a case, but only two persons sat adjacent to a case and were contacttraced. We note that several persons who sat adjacent to an index case were close contacts that were excluded from the risk factor analysis. Additionally, we could not assess the impact of flight time on risk, as all cases were on flights between 1.5 and 2.5 hours long, and not on shorter or longer flights.

This study benefits from a wealth of data collected for COVID-19

contact-tracing purposes, as well as a thorough method using both manual review and data linkage. In particular, this included the extraction of onset dates (found in 59 of 72 cases), and identification of passengers who lived or travelled with an index case, by reviewing flight booking information in the manifest as well as contact-tracing notes. Due to linkage to the national line list using electronic airplane manifests, which typically contain accurate patient information, we are reasonably confident that we identified most, if not all, laboratory-confirmed cases associated with these flights.

However, risk of transmission in this setting remains difficult to quantify, and under-ascertainment is a major limitation to this study.

Our risk estimate does not represent total risk of acquiring infection, including asymptomatic cases, which could only be estimated

if all passengers were systematically tested. It is likely that there were several undetected cases, including mildly symptomatic cases or persons not reached by contact tracing, who therefore did not know they were eligible for testing. 13 Other cases may have been unknown to PHE due to onward travel and diagnosis abroad.

Misclassification of exposure may also have occurred: some "flight-only" cases or seat numbers may have been misidentified due to incomplete information on passenger interactions or movements.

The majority of passengers who sat within two rows of an index case were not contact-traced, in part because contact tracing for some flights was ceased as England transitioned from containment to delay phase, and because contemporaneous guidance only considered a passenger to be infectious if symptomatic on the flight. 4

On balance, it is likely that we have underestimated the number of passengers who were infected with SARS-CoV-2, but among them we may have overestimated the number that were due to acquisition on aircraft. Acquisition of SARS-CoV-2 may have occurred prior to departure, at other points during travel, or upon return. 14 Predeparture acquisition is particularly likely due to the high incidence in the departures cities at the time, 15 We conclude that risk of symptomatic COVID-19 due to transmission on short to medium haul flights is likely low, at approximately 3% but less than 10% if sat within two rows of an infectious individual. This is consistent with the low numbers of aircraft-acquired secondary cases seen in some other published contact-tracing analyses, [6] [7] [8] although lower the 62% attack rate found in Khanh et al's 10 study of a 10 hours flight. These differences may be because we investigated shorter flights, ruled out more close contacts from possible aircraft transmission, or had lower case ascertainment. Differences in aircraft ventilation and filtering systems are also possible, 16 although these details were unavailable for this study.

The risk identified in this paper is relevant to England's containment period, so may be higher than risk on flights later in the pandemic, due to measures taken within the aviation industry. Guidance This study was not able to propose specific social distancing recommendations on aircraft or changes to the two-seat eligibility criteria for contact tracing. While cases beyond two rows were identified, we also cannot rule out transmission outside of the flight for these persons. However, the significantly higher attack rates among close contacts and co-travellers suggest these should be prioritised over persons with flight-only contact where resources are limited, and particularly where flight journeys are short. Such contacts are likely higher risk due to closer and more prolonged exposure, unlike unfamiliar co-passengers who are less likely to interact and face each other during the flight. 5 With potential for asymptomatic infection and more than a quarter of index cases developing symptoms after the flight, our findings also highlight the importance of post-flight quarantine from high-incidence areas to prevent case importation.

There should be continued efforts to study and communicate modifiable risk factors for transmission on flights, to inform flight planning and to help travellers make informed choices on travel abroad.

We write this article with great appreciation of the Contact Tracing

Cell, Health Protection Teams, Field Services, Surveillance Cell, Genomics Cell, and Epidemiology Cell within Public Health England as well as local authorities, port health authorities, airlines, and passengers involved in the COVID-19 surveillance and contact tracing that contributed to this research and control of COVID-19 in England more widely.

We have no conflicts of interest to declare. 

The peer review history for this article is available at https://publo ns.com/publo n/10.1111/irv.12846.

Paula Bianca Blomquist https://orcid. org/0000-0002-3962-4211

l/30-01-2020-state ment-on-the-secon d-meeti ng-of-the-inter natio nal-healt h-regul ation s-(2005)-emerg ency-commi ttee-regar ding-the-outbr eak-ofnovel

World Health Organisation. WHO Coronavirus Disease (COVID-19). Dashboard. 5

Press release: COVID-19: government announces moving out of contain phase and into delay

Public Health Management of Contacts of Possible and Confirmed Human Cases of COVID-19 (version 3.00)

5c878 6230f f34e2 da406 c72a5 2030e 95/safel y-resta rt-aviat ion-joint -aci-iata-appro ach

Lack of COVID-19 Transmission on an International Flight

The first 2 months of covid-19 contact tracing in the northern territory of Australia

Possible aircraft transmission of COVID-19 in-flight from the Central African Republic to France

In-Flight Transmission of Severe Acute Respiratory Syndrome Coronavirus 2

Transmission of severe acute respiratory syndrome coronavirus 2 during long flight

On the 2-Row Rule for Infectious Disease Transmission on Aircraft. Annals of Global Health

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis

FlyHealthy Research Team. Behaviours, movements, and transmission of dropletmediated respiratory disease during transcontinental airline flights

COVID-19) in the EU/EEA and the UK -eighth update

European Centre for Disease Prevention and Control and the European Centre for Disease prevention. COVID-19 Aviation Health Safety Protocol: Operational guidelines for the management of air passengers and aviation personnel in relation to the COVID-19 pandemic

FAQs on the wearing of face masks

Looking after you in the air

British Airways. Welcome on board

Health Alert and Emergency Co-ordination Centre (CCAES): Spain Travel Health

Government of the Netherlands. Negative COVID-19 test result and declaration on arrival in the Netherlands

Portugal Travel Advice

Covid-19 Testing Information

Risk of symptomatic COVID-19 due to aircraft transmission: a retrospective cohort study of contact-traced flights during

England's containment phase